Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Blaese

Showing results (11-20 of 226) with videos related to

Pageof 23
Sort By:
Clinical and Experimental Immunology|April 1, 1973
Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS)G Sherwood, R M Blaese
Kroc Foundation Series|January 1, 1985
Defective allosuppression in patients with ataxia-telangiectasiaG Tosato, R M Blaese
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Gene therapy of cancerC A Mullen, R M Blaese
Allergologia Et Immunopathologia|January 1, 1991
Prospects for gene therapy of human diseaseR M Blaese, K W Culver
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1971
Hemolytic anemia in agammaglobulinemic chickens: a model of "autoimmune" disease in immune deficiencyP L Weiden, R M Blaese
The Journal of Pediatrics|August 1, 1974
Monoclonal gammopathy in the Wiskott-Aldrich syndromeR M Bruce, R M Blaese
Immunodeficiency Reviews|January 1, 1992
Gene therapy for primary immunodeficiency diseaseR M Blaese, K W Culver
BMJ (Clinical Research Ed.)|November 24, 1999
Gene therapy: lessons learnt from the past decade. Interview by Clare ThompsonR A Morgan, R M Blaese
The Journal of Pediatrics|February 1, 1972
Hereditary thrombocytopenia: relation to Wiskott-Aldrich syndrome with special reference to splenectomy. Report of a family and review of the literatureP L Weiden, R M Blaese
Mead Johnson Symposium on Perinatal and Developmental Medicine|January 1, 1986
The mononuclear phagocyte system: the heart of host defenseR M Blaese, A V Muchmore
Pageof 23

Showing results (11-20 of 226) with videos related to

Sort By:
Pageof 23
Clinical and Experimental Immunology|April 1, 1973
Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS)G Sherwood, R M Blaese
Kroc Foundation Series|January 1, 1985
Defective allosuppression in patients with ataxia-telangiectasiaG Tosato, R M Blaese
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Gene therapy of cancerC A Mullen, R M Blaese
Allergologia Et Immunopathologia|January 1, 1991
Prospects for gene therapy of human diseaseR M Blaese, K W Culver
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1971
Hemolytic anemia in agammaglobulinemic chickens: a model of "autoimmune" disease in immune deficiencyP L Weiden, R M Blaese
The Journal of Pediatrics|August 1, 1974
Monoclonal gammopathy in the Wiskott-Aldrich syndromeR M Bruce, R M Blaese
Immunodeficiency Reviews|January 1, 1992
Gene therapy for primary immunodeficiency diseaseR M Blaese, K W Culver
BMJ (Clinical Research Ed.)|November 24, 1999
Gene therapy: lessons learnt from the past decade. Interview by Clare ThompsonR A Morgan, R M Blaese
The Journal of Pediatrics|February 1, 1972
Hereditary thrombocytopenia: relation to Wiskott-Aldrich syndrome with special reference to splenectomy. Report of a family and review of the literatureP L Weiden, R M Blaese
Mead Johnson Symposium on Perinatal and Developmental Medicine|January 1, 1986
The mononuclear phagocyte system: the heart of host defenseR M Blaese, A V Muchmore
Pageof 23